Outcomes With Transcatheter Mitral Valve Repair in the United States

TMVR is being performed effectively and safely for severely symptomatic patients with MR and prohibitive surgical risk in the United States. Within 1 year of therapy, mortality occurs in approximately one-fourth of patients, and approximately one-fifth are rehospitalized for heart failure. These adverse events are related to age and associated with decreased left ventricular function, functional MR, severe tricuspid regurgitation, moderate or severe lung disease, and post-procedural residual MR.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *